| Identification | Back Directory | [Name]
2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]- | [CAS]
1237168-58-9 | [Synonyms]
Fosifidancitinib Janus kinase,JAK,Inhibitor,Fosifidancitinib,inhibit 2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]- | [Molecular Formula]
C21H21FN5O7P | [MDL Number]
MFCD34578235 | [MOL File]
1237168-58-9.mol | [Molecular Weight]
505.39 |
| Hazard Information | Back Directory | [Uses]
Fosifidancitinib is a potent and selective inhibitor of JAK kinases 1/3. Fociatinib is used in studies of allergies, asthma and autoimmune diseases[1]. | [References]
[1] Li, Hui; Heckrodt, Thilo J.; Chen, Yan; Mcmurtrie, Darren John; Taylor, Vanessa; Singh, Rajinder; Ding, Pingyu; Yen, Rose.Preparation of phenylaminopyrimidinylaminooxobenzooxazole derivatives for use as JAK kinase inhibitors. WO2012015972A1 |
|
|